| ProtoKinetix (OTCBB: PKTX) (www.protokinetix.com) is pleased to announce results from Areta International laboratory in Italy. These results show dramatic increases in the production of monoclonal antibodies when AAGP™ is incorporated into the production cycle. Monoclonal antibodies are one of the fastest growing sectors of the pharmaceutical industry. This market is presently over $50-billion USD per year and growing rapidly. As a therapeutic, monoclonal antibodies do not cause the same side-effe...continued PKTX Services |
Wednesday, December 7, 2011
Italian Laboratory Expands ProtoKinetix' Market for AAGP(tm)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment